GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.